{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":37,"cheight":29,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500727.png","picWidth":40,"picHeight":29,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

联系电话：0851-33411018（行政部）   0851-88173360（销售部）    股票代码：SZ 002424

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":550,"cheight":381,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889249.png","picWidth":550,"picHeight":381,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
贵州百灵企业集团制药股份有限公司
股票代码：SZ 002424
查看更多最新公告>
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":634,"cheight":56,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500733.png","picWidth":630,"picHeight":56,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

走进百灵

专精于药 · 专注于人

 贵州百灵企业集团制药股份有限公司（以下简称“贵州百灵”）是一家从事苗药研发、生产、销售于一体的医药上市公司，注册资本14.112亿元，总资产70.59亿元，员工6124人。2010年6月，公司在深圳证券交易所成功上市（股票代码：SZ 002424）。公司明确围绕“强化公司在苗药领域的优势地位，力争成为中成药领域具有核心竞争优势的企业”为战略发展目标，以实施“科技苗药、文化苗药、生态苗药”为抓手，致力打造拥有大健康全产业链的企业集团。

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":365,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集团概况","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889219.png","picWidth":360,"picHeight":129,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集团概况","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集团概况","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889221.png","picWidth":"373","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集团概况","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"药材基地","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889220.png","picWidth":"363","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"药材基地","linkKey":"page","linkUrl":"page.html?id=675381845688358","jsonData":{}}}
致力于推动苗药品种的科研创新
实现传统苗药现代化、科技化

持续挖掘和探索苗药宝库，以传承

和发扬民族医药文化为企业使命

布局中药材种植产业，加强道地

药材保护，助力产业化精准扶贫

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":754,"picHeight":61,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

产品与服务

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":752,"picHeight":61,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
  • 非处方药
  • 处方药
  • 大健康产品
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":591,"cheight":57,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049634500734.png","picWidth":590,"picHeight":57,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

百灵动态

关注百灵了解更多最新资讯

  • 百灵新闻
  • 媒体聚焦
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":264,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=950846535762032","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/980936413937715.png","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=950846535762032","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=950846535762032","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=950846535762029","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/980936413937712.jpg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=950846535762029","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=950846535762029","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":278,"cheight":162,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=950846535762026","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/980936413937710.jpg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=950846535762026","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=950846535762026","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":164,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=950846535762022","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/980936413937714.jpg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=950846535762022","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=950846535762022","jsonData":{}}}

贵州百灵咳速停糖浆等产品入选中国中药协会《新冠病毒感染防治“两保一稳”清单》

贵州省委书记徐麟赴贵州百灵慰问调研

助力抗疫，共度时艰——贵州百灵捐赠63万余元药品物资用于安顺市特殊群体疫情防控

贵州百灵糖宁通络“头对头”临床研究期中报告：疗效优势持续扩大！

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"20","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":22,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":21,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"21","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2023-01-04

2022-12-31

2022-12-29

2022-12-21

12月28日，贵州百灵通过安顺市红十字会向安顺市民政局捐赠了63万余元的宝贵药品物资，包含咳速停糖浆、金感胶囊、维C银翘片、小儿柴桂退热颗粒等药品及医用防护口罩等物资，用于全市孤儿、事实无人抚养儿童、特困供养对象的疫情防控…详细>

12月19日晚间，贵州百灵披露“糖宁通络”国家级科研课题最新进展，公司收到课题组关于子课题《糖宁通络片随机、开放、阳性药平行对照、多中心治疗糖尿病视网膜病变非增殖期-阴虚内热、目络瘀阻证的有效性及安全性临床研究》第二次期中分析报告…详细>

12月30日，贵州省委书记徐麟赴贵州百灵实地调研，并亲切慰问一线干部职工，向加班加点保生产的同志们致以节日的问候。徐麟书记强调，当前正值疫情防控措施调整转段关键时期…详细>

日前，中国中药协会召开理事会扩大会议，发布《新冠病毒感染防治“两保一稳”清单》。贵州百灵“咳速停糖浆、双羊喉痹通颗粒、复方一枝黄花喷雾剂、感清糖浆”等产品入选成人用药清单，“小儿柴桂退热颗粒”入选儿童用药清单…详细>

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=944654853865590","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/939399231570033.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=944654853865590","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=944654853865590","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":280,"cheight":180,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=944654837088361","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/939399055409194.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=944654837088361","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=944654837088361","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":200,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"中国证券报 | 贵州百灵：甲磺酸普依司他治疗复发或难治弥漫大B淋巴瘤进入Ⅱ期临床","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/939399231570022.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"中国证券报 | 贵州百灵：甲磺酸普依司他治疗复发或难治弥漫大B淋巴瘤进入Ⅱ期临床","linkUrl":"中国证券报 | 贵州百灵：甲磺酸普依司他治疗复发或难治弥漫大B淋巴瘤进入Ⅱ期临床","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":268,"cheight":163,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"https://www.gzbl.com/displaynews.html?newsId=944654837088275","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/939399038632043.jpg","picWidth":"300","picHeight":"366","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"https://www.gzbl.com/displaynews.html?newsId=944654837088275","linkUrl":"https://www.gzbl.com/displaynews.html?newsId=944654837088275","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2022-09-23

 

2022-09-15

2022-09-03

2022-08-29

上海证券报 | 贵州百灵上半年业绩逆势小幅增长 糖宁通络国家课题等获重大进展

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":751,"cheight":64,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"//oss.xinghuo86.cn/666753113784399/698049642889216.png","picWidth":751,"picHeight":64,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

投资者关系

与您共享贵州百灵的发展和成绩